Tryptophan metabolism and its role in fibroid pathogenesis

色氨酸代谢及其在肌瘤发病机制中的作用

基本信息

项目摘要

Abstract In the course of our profiling for non-coding RNAs in fibroids we discovered highly aberrant overexpression of Tryptophan 2,3 dioxygenase (TDO2) and Indoleamine 2,3-dioxygenase (IDO1) in fibroids. We confirmed this finding by both qRT-PCR and Western blot analysis, and found a consistently elevated expression of TDO2 and more variable overexpression of IDO1 in our tissue specimens. The increment in TDO2 expression in fibroids was higher as compared to IDO1, and the expression of IDO2 was barely detected. Relevant to the pathogenesis of fibroids was that the increment in TDO2 but not IDO1 was race dependent, with the increment being significantly higher in African Americans as compared with Caucasians. Furthermore, the expression of TDO2 was significantly increased in MED12 mutation bearing leiomyomas, and its inhibition by pharmacologic blockade in vitro led to decreased proliferation and expression of genes related to extracellular matrix, inflammation and cell growth in leiomyoma smooth muscle cells (LSMC) spheroids. Aberrant expression of these enzymes in fibroids resulted in increased levels of kynurenine (Kyn), a metabolic byproduct of tryptophan degradation and a known endogenous ligand for Aryl hydrocarbon receptor (AhR). Based on this preliminary data we hypothesized that dysregulation of Trp metabolism as characterized by marked overexpression of TDO2 is fundamental to the pathogenesis of fibroids and correction of Trp metabolic dysregulation by inhibition of TDO2 and normalization of kynurenine levels will inhibit fibroid growth and progression and potentially tumor establishment. We propose to this hypothesis in 3 aims. In aim1 we will characterize Trp metabolism in myometrium and fibroid tumors and explants, and determine the mechanism(s) underlying the marked overexpression of TDO2 in fibroids using an in vitro approach. In Aim 2 we will examine the impact of kynurenine and its activation of AhR on downstream genes regulating extracellular matrix (ECM), inflammation and cell proliferation. Aim 3 is designed to determine the utility of a pharmacological inhibitor of TDO2 and with lentivirus bearing shRNA to knock down TDO2 on fibroid establishment and progression in in vivo mouse models of fibroids. This novel metabolic mechanism for fibroid pathogenesis has great translational significance as it opens the way for novel therapies aimed at correction of tryptophan metabolism in fibroids.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OMID A. KHORRAM其他文献

OMID A. KHORRAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OMID A. KHORRAM', 18)}}的其他基金

Tryptophan metabolism and its role in fibroid pathogenesis
色氨酸代谢及其在肌瘤发病机制中的作用
  • 批准号:
    10708871
  • 财政年份:
    2022
  • 资助金额:
    $ 38.53万
  • 项目类别:
Function of Long Non-Coding RNA MD1 in Leiomyoma Pathogenesis
长链非编码RNA MD1在平滑肌瘤发病机制中的作用
  • 批准号:
    10156935
  • 财政年份:
    2021
  • 资助金额:
    $ 38.53万
  • 项目类别:
Function of Long Non-Coding RNA MD1 in Leiomyoma Pathogenesis
长链非编码RNA MD1在平滑肌瘤发病机制中的作用
  • 批准号:
    10370413
  • 财政年份:
    2021
  • 资助金额:
    $ 38.53万
  • 项目类别:
Mechanism of Long Non-coding RNAs Action in leiomyoma
长链非编码RNA在平滑肌瘤中的作用机制
  • 批准号:
    10662468
  • 财政年份:
    2020
  • 资助金额:
    $ 38.53万
  • 项目类别:
Mechanism of Long Non-coding RNAs Action in leiomyoma
长链非编码RNA在平滑肌瘤中的作用机制
  • 批准号:
    10436359
  • 财政年份:
    2020
  • 资助金额:
    $ 38.53万
  • 项目类别:
Mechanism of Long Non-coding RNAs Action in leiomyoma
长链非编码RNA在平滑肌瘤中的作用机制
  • 批准号:
    10330338
  • 财政年份:
    2020
  • 资助金额:
    $ 38.53万
  • 项目类别:
Mechanism of Long Non-coding RNAs Action in leiomyoma
长链非编码RNA在平滑肌瘤中的作用机制
  • 批准号:
    10256031
  • 财政年份:
    2020
  • 资助金额:
    $ 38.53万
  • 项目类别:
Mechanism of Long Non-coding RNAs Action in leiomyoma
长链非编码RNA在平滑肌瘤中的作用机制
  • 批准号:
    10053201
  • 财政年份:
    2020
  • 资助金额:
    $ 38.53万
  • 项目类别:
Glucocorticoids and Programming of the Hypertensive Vascular Phenotype
糖皮质激素和高血压血管表型的编程
  • 批准号:
    7316053
  • 财政年份:
    2007
  • 资助金额:
    $ 38.53万
  • 项目类别:
Human Endometrial Nitric Oxide: Regulation and Function
人子宫内膜一氧化氮:调节和功能
  • 批准号:
    6417231
  • 财政年份:
    2002
  • 资助金额:
    $ 38.53万
  • 项目类别:

相似海外基金

The Role of CD96hi Cells Mediated by Transcription Factor Aryl Hydrocarbon Receptor (AHR) in HIV Pathogenesis.
转录因子芳基烃受体 (AHR) 介导的 CD96hi 细胞在 HIV 发病机制中的作用。
  • 批准号:
    502605
  • 财政年份:
    2024
  • 资助金额:
    $ 38.53万
  • 项目类别:
Understanding the origins and mechanisms of aryl hydrocarbon receptor promiscuity
了解芳烃受体混杂的起源和机制
  • 批准号:
    10679532
  • 财政年份:
    2023
  • 资助金额:
    $ 38.53万
  • 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
  • 批准号:
    487508
  • 财政年份:
    2023
  • 资助金额:
    $ 38.53万
  • 项目类别:
    Operating Grants
Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
鉴定芳基烃受体作为 HIV-1 潜伏期的新型药物调节剂
  • 批准号:
    493698
  • 财政年份:
    2023
  • 资助金额:
    $ 38.53万
  • 项目类别:
    Operating Grants
Elucidation of the essential mechanism of action of aryl hydrocarbon receptor agonists on breast cancer cells
阐明芳烃受体激动剂对乳腺癌细胞作用的基本机制
  • 批准号:
    23K14396
  • 财政年份:
    2023
  • 资助金额:
    $ 38.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Regulation of long-noncoding RNA (lncRNA) by the aryl hydrocarbon receptor
芳烃受体对长链非编码 RNA (lncRNA) 的调节
  • 批准号:
    RGPIN-2020-04462
  • 财政年份:
    2022
  • 资助金额:
    $ 38.53万
  • 项目类别:
    Discovery Grants Program - Individual
The aryl hydrocarbon receptor (AhR) controls myofibroblast differentiation via lncRNA
芳烃受体 (AhR) 通过 lncRNA 控制肌成纤维细胞分化
  • 批准号:
    573498-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 38.53万
  • 项目类别:
    University Undergraduate Student Research Awards
Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action
肝芳基烃受体对肥胖的调节:作用机制
  • 批准号:
    10701901
  • 财政年份:
    2022
  • 资助金额:
    $ 38.53万
  • 项目类别:
The impact of Aryl hydrocarbon receptor signaling on Toll like receptor-mediated inflammation
芳基碳氢化合物受体信号传导对 Toll 样受体介导的炎症的影响
  • 批准号:
    10569113
  • 财政年份:
    2022
  • 资助金额:
    $ 38.53万
  • 项目类别:
The impact of Aryl hydrocarbon receptor signaling on Toll like receptor-mediated inflammation
芳基碳氢化合物受体信号传导对 Toll 样受体介导的炎症的影响
  • 批准号:
    10367788
  • 财政年份:
    2022
  • 资助金额:
    $ 38.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了